• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Enzo Biochem (NY: ENZ )

    1.130 UNCHANGED
    Streaming Delayed Price Updated: 10:37 AM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Enzo Biochem

    < Previous 1 2 3 Next >
    Why Is Histogen (HSTO) Stock Up 37% Today?
    Histogen (HSTO) stock is rising higher on Friday after getting a patent for CTS-2090 that protects its products through 2040. 
    Via InvestorPlace
    Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
    Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
    Via InvestorPlace
    Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
    Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. 
    Via Benzinga
    Why Enzo Biochem Stock Is Skyrocketing After Hours
    Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
    Via Benzinga
    Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying
    The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Nasdaq Rises 100 Points; Gold Gains Over 1%
    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday 
    Via Benzinga
    Dow Turns Lower; Crude Oil Rises Sharply
    U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 49 companies hit new 52-week lows. 
    Via Benzinga
    Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
    Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
    Via Benzinga
    Earnings Scheduled For December 12, 2022
    Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is projected to report earnings for its second quarter. 
    Via Benzinga
    Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW
    From Farmer Bros. Co.
    Via GlobeNewswire
    Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
    - David Bench resigning to pursue a new career opportunity - 
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Earnings Scheduled For October 14, 2022
    Companies Reporting Before The Bell • Wells Fargo (NYSE:WFC) is estimated to report quarterly earnings at $1.08 per share on revenue of $18.77 billion. 
    Via Benzinga
    Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
    From Enzo Biochem, Inc.
    Via GlobeNewswire
    Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
    Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. 
    Via Benzinga
    Earnings Scheduled For June 9, 2022
    Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report quarterly loss at $0.05 per share on revenue of $14.64 million. 
    Via Benzinga
    The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
    Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For March 14, 2022
    Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (... 
    Via Benzinga
    The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
    Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... 
    Via Benzinga
    The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.